Shandong Wohua Pharmaceutical Co., Ltd.

SZSE:002107.SZ

6 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 894.3151,014.818942.6751,006.082860.291774.416726.646562.846468.924315.308255.598209.607149.02990.921172.196196.541129.449122.676111.32891.41974.734
Cost of Revenue 241.435250.884212.378223.008201.502177.265156.7142.598129.63283.95155.52245.78234.59824.72740.90167.72426.01322.81820.43318.2915.773
Gross Profit 652.879763.934730.296783.074658.788597.151569.946420.248339.292231.357200.075163.825114.43166.194131.295128.817103.43699.85790.89673.12958.961
Gross Profit Ratio 0.730.7530.7750.7780.7660.7710.7840.7470.7240.7340.7830.7820.7680.7280.7620.6550.7990.8140.8160.80.789
Reseach & Development Expenses 43.29650.10847.47846.69752.24840.49515.63253.09124.46249.93219.59417.16000000000
General & Administrative Expenses 17.34117.37412.13612.32513.42312.74120.70821.15815.0578.34124.26222.72415.92620.15413.7549.2528.48410.93512.36111.20610.881
Selling & Marketing Expenses 491.772521.016421.813470.521448.331457.045390.365288.627207.078173.186164.424130.49991.96280.2565.44544.54343.47642.58534.08524.424.404
SG&A 560.945538.39433.948482.846461.754469.786411.073309.785222.135181.527188.686153.223107.889100.40479.19953.79551.9653.52146.44535.60635.286
Other Expenses -2.30862.98441.93436.9131.5951.6619.2268.0069.8536.925-1.06-1.3373.8167.44315.0678.1147.3467.1850.409-0.4070.025
Operating Expenses 606.55651.482523.36566.453545.597542.233448.175347.828258.055202.651193.63157.201110.59101.68381.75656.63854.14555.63248.36437.00736.408
Operating Income 46.33112.314192.686222.602111.42944.18291.7766.62178.21528.6469.0356.0224.463-99.84147.4662.28240.70337.54534.89428.0615.469
Operating Income Ratio 0.0520.1110.2040.2210.130.0570.1260.1180.1670.0910.0350.0290.03-1.0980.2760.3170.3140.3060.3130.3070.207
Total Other Income Expenses Net 8.308-1.521-2.731-2.1511.492-11.318-30.074-2.2894.2527.8434.1791.7213.602-61.88412.989-9.078-8.587-6.874-8.058-8.549-7.424
Income Before Tax 54.638110.793189.956220.451112.9243.60191.69870.13185.48836.54910.6248.3457.442-97.37462.52763.10140.70337.58434.88827.61315.311
Income Before Tax Ratio 0.0610.1090.2020.2190.1310.0560.1260.1250.1820.1160.0420.040.05-1.0710.3630.3210.3140.3060.3130.3020.205
Income Tax Expense 8.01120.90728.63334.12615.683.60510.98.6773.560.0010.0030.0050.0090.43810.1549.4635.2836.0826.4524.482.824
Net Income 58.767107.386163.392178.8895.80245.65257.03248.80971.36636.54810.6218.347.433-97.81252.37353.63835.4231.50328.43723.13312.487
Net Income Ratio 0.0660.1060.1730.1780.1110.0590.0780.0870.1520.1160.0420.040.05-1.0760.3040.2730.2740.2570.2550.2530.167
EPS 0.10.190.280.310.170.0810.10.0880.130.0750.0170.0140.014-0.170.0910.0990.0720.0870.0780.0630.044
EPS Diluted 0.10.190.280.310.170.0810.10.0880.130.0750.0170.0140.014-0.170.0910.0990.0720.0870.0780.0630.044
EBITDA 79.553150.83242.773258.543137.59782.31162.77290.996108.27144.51821.17123.44712.888-29.83361.87373.42748.43343.6640.59234.47221.148
EBITDA Ratio 0.0890.1490.2580.2570.160.1060.2240.1620.2310.1410.0830.1120.086-0.3280.3590.3740.3740.3560.3650.3770.283